Pharma
RAREfest24: Saturday Exhibition - Science, Technology, Community, Arts
A festival as unique as you are. For curious minds of all ages. Engage, Educate, Empower, Transform: Join the RAREfest24 Movement! ...
The role of Telehealth in managing chronic lung conditions
An In-depth Conversation with Dr. Andrew Potter of Whaddon Medical Centre
Nxera Pharma highlights latest results
Tokyo, Japan and Cambridge, UK, 9 August 2024 – Nxera Pharma provides an update on operational activities and reports its consolidated results for the second quarter and first half ended 30 June 2024. ...
lungDx Technology and ILD: White Paper
“Improperly treated ILD is associated with a poorer quality of life, an increased risk of life-threatening complications and early mortality.” This white paper provides a comprehensive overview of the pathogenesis of interstitial, its diagnosis and monitoring, and available treatment o...
Functional genomic screens and AI: a key partnership for successful therapeutic development
Join Cambridge Network and the Milner Therapeutics Institute to explore the world of genomics and AI in developing therapies for human disease. ...
Empowering children and young people to become DNA heroes
D-CYPHR attended Leicester Grammar School STEM fair to highlight how every family can help childhood health research. Children and young people at the school have been involved in D-CYPHR for a while and it was a great chance to bring the project to life. ...
BioResource participant samples used in research discovering major cause of IBD
BioResource volunteers have contributed to new research from The Francis Crick Institute - in collaboration with UCL and Imperial College London - which discovered a new biological pathway as the principal driver of Inflammatory Bowel Disease (IBD) and related conditions, and which can ...
Ground-breaking study proves AI-driven programme has comparable effectiveness to human-delivered care while using up to 8 times fewer therapist hours
A new study by ieso Digital Health in collaboration with the and NIHR BioResource reveals that its AI-driven digital programme delivered results comparable to traditional human-led therapy for generalised anxiety. An estimated 1.2 million people in the UK are on waiting lists for NHS me...
Dylan shares his inspiring story on how all families can be part of research
Dylan reveals how he had major open heart surgery at just 7 years old. He joined the D-CYPHR programme and became a DNA hero to inspire others. ...
New genetic cause of obesity could help guide treatment
Researchers working with the NIHR BioResource discovered a genetic link between a specific blood group deficiency and obesity. The study identified a genetic variant affecting the SMIM1 gene, leading to higher body weight due to reduced energy expenditure at rest in Vel-negative individ...